153 related articles for article (PubMed ID: 8629294)
21. Effect of OKT3 in steroid-resistant renal transplant rejection.
Petrie JJ; Rigby RJ; Hawley CM; Suranyi MG; Whitby M; Wall D; Hardie IR
Transplantation; 1995 Feb; 59(3):347-52. PubMed ID: 7871563
[TBL] [Abstract][Full Text] [Related]
22. A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants.
Flechner SM; Goldfarb DA; Fairchild R; Modlin CS; Fisher R; Mastroianni B; Boparai N; O'Malley KJ; Cook DJ; Novick AC
Transplantation; 2000 Jun; 69(11):2374-81. PubMed ID: 10868643
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
[TBL] [Abstract][Full Text] [Related]
24. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.
Midtvedt K; Fauchald P; Lien B; Hartmann A; Albrechtsen D; Bjerkely BL; Leivestad T; Brekke IB
Clin Transplant; 2003 Feb; 17(1):69-74. PubMed ID: 12588325
[TBL] [Abstract][Full Text] [Related]
25. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
26. Tacrolimus rescue therapy in patients with rejection and long-term dialysis after kidney transplantation.
Witzke O; Becker G; Erhard J; Lütkes P; Szabo A; Philipp T; Heemann U
Clin Nephrol; 1998 Jan; 49(1):24-7. PubMed ID: 9491282
[TBL] [Abstract][Full Text] [Related]
27. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
[TBL] [Abstract][Full Text] [Related]
28. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
29. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
30. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
Aw MM; Taylor RM; Verma A; Parke A; Baker AJ; Hadzic D; Muiesan P; Rela M; Heaton ND; Mieli-Vergani G; Dhawan A
Transplantation; 2003 Mar; 75(6):796-9. PubMed ID: 12660504
[TBL] [Abstract][Full Text] [Related]
31. Rescue FK506 early conversion for refractory rejection after pediatric liver transplantation: experience in 20 children.
Reggiani P; Gridelli B; Colledan M; Rossi G; Lucianetti A; Galmarini D; Fassati LR
Transpl Int; 1998; 11 Suppl 1():S272-4. PubMed ID: 9664995
[TBL] [Abstract][Full Text] [Related]
32. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
McDiarmid SV; Wallace P; Vargas J; Ament ME; Busuttil RW
J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):291-9. PubMed ID: 7541834
[TBL] [Abstract][Full Text] [Related]
33. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
[TBL] [Abstract][Full Text] [Related]
34. Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Jing-Ding W; Miki T; Okuyama A
Transpl Int; 1998; 11 Suppl 1():S60-4. PubMed ID: 9664945
[TBL] [Abstract][Full Text] [Related]
35. FK506 conversion therapy in pediatric liver transplantation.
Egawa H; Esquivel CO; So SK; Cox K; Concepcion W; Lawrence L
Transplantation; 1994 Apr; 57(8):1169-73. PubMed ID: 7513911
[TBL] [Abstract][Full Text] [Related]
36. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
38. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
[TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of rejection after simultaneous pancreas-kidney transplantation.
Yang L; Liu YF; Liu SR; Wu G; Zhang JL; Meng YM; Shong SW; Li GC
Chin Med Sci J; 2005 Sep; 20(3):210-3. PubMed ID: 16261897
[TBL] [Abstract][Full Text] [Related]
40. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]